MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
September 29, 2011
Dan Caplinger
Has Rite Aid Become the Perfect Stock? The company needs to turn itself around first before anyone will seriously expect superior results from Rite Aid. mark for My Articles similar articles
The Motley Fool
August 2, 2011
Anand Chokkavelu
5 Advertising Stocks Near 52-Week Lows Trolling the bottom for upside potential. mark for My Articles similar articles
The Motley Fool
February 10, 2009
Dan Caplinger
5 Stocks You'd Be Crazy to Buy Now If your stocks have absolutely nothing going for them, you really owe it to yourself to pull the plug and move on -- no matter how painful it may be. mark for My Articles similar articles
The Motley Fool
August 19, 2005
Philip Durell
How to Use the P/E The price-to-earnings ratio is a widely used -- and misused -- investing metric. Do you use it correctly? mark for My Articles similar articles
The Motley Fool
November 15, 2005
Philip Durell
How to Use the P/S Ratio No earnings? No problem! Learn how to value companies using the price-to-sales ratio. mark for My Articles similar articles
The Motley Fool
August 30, 2011
Ilan Moscovitz
YRC Worldwide Is Better Than You Think YRC has a tendency to generate much more free cash flow than net income, suggesting the beleaguered and restructuring trucking company is not as unprofitable as many investors might think. mark for My Articles similar articles
The Motley Fool
August 19, 2011
Ilan Moscovitz
Rite Aid Is Cheaper Than You Think Rite Aid tends to generate much more free cash flow than net income, suggesting that -- while things may not exactly be going swimmingly -- the company's stock might be a bit cheaper than many investors realize. mark for My Articles similar articles
The Motley Fool
May 19, 2010
Selena Maranjian
You Can Have Tech and Dividends Many investors believe that they have to choose between slow-growing, dividend-paying blue chips, or rapidly expanding, payout-free tech companies. That used to be the case -- but not anymore. mark for My Articles similar articles
The Motley Fool
April 10, 2006
Foolish Fundamentals: The Price-to-Sales Ratio The P/S is a handy tool for investors that can go places the price-to-earnings (P/E) ratio can't. mark for My Articles similar articles
The Motley Fool
July 13, 2005
Dan Bloom
Drilling for Value The price-to-sales ratio suggests that Transocean and Diamond Offshore aren't bargains. the drilling business is highly volatile. If earnings fail to materialize, investors will likely feel a lot of pain. mark for My Articles similar articles
The Motley Fool
June 25, 2004
Steven Mallas
Rite Aid in the Shadows The first quarter for Rite Aid, the pharmaceutical retailer, shows a profit, but is it time to add this stock to your portfolio? mark for My Articles similar articles
The Motley Fool
December 5, 2007
Sham Gad
Watch Out for the P/E Ratio While the P/E ratio is a very useful resource, its often-ignored limitations can sometimes catch smart investors off guard. Use it carefully and prudently. mark for My Articles similar articles
The Motley Fool
September 8, 2010
Rick Aristotle Munarriz
YRC Wants to Keep On Trucking The trucking giant fights off exchange delisting. mark for My Articles similar articles
The Motley Fool
October 21, 2010
Anand Chokkavelu
9 Basic Stocks Near 52-Week Lows Here are the largest food and staples stocks by market cap that are hugging 52-week lows: Wal-Mart... CVS... Costco... SYSCO... Kroger... Companhia Brasileira... Safeway... Delhaize... Rite Aid... mark for My Articles similar articles
The Motley Fool
January 4, 2005
Seth Jayson
Rite Aid Still Needs First Aid Sales keep slacking for this tough turnaround. This doesn't mean investors should necessarily jump ship. mark for My Articles similar articles
The Motley Fool
June 21, 2006
Rich Smith
Foolish Forecast: Rite Aid Revival? Will tomorrow's earnings news make it three bad quarters in a row for the retail pharmacy? Investors, take note. mark for My Articles similar articles
The Motley Fool
October 18, 2010
Matt Koppenheffer
YRC Worldwide Shares Popped: What You Need to Know Shares of trucker YRC Worldwide were up more than 13% in intraday trading today as investors cheered the company's earnings preannouncement. mark for My Articles similar articles
The Motley Fool
July 30, 2010
Anand Chokkavelu
4 Stocks to Consider Before Buying FedEx If you like FedEx, you may like these transportation, utility, and auto stocks better. mark for My Articles similar articles
The Motley Fool
October 11, 2010
Matt Koppenheffer
YRC Worldwide Shares Plunged: What You Need to Know Shares of trucker YRC Worldwide were down more than 10% in intraday trading. mark for My Articles similar articles
The Motley Fool
August 25, 2010
Jordan DiPietro
How Safe Are SUPERVALU's Dividends? SUPERVALU, which operates in the food retail industry, pays a dividend of 3.5%. But what's more important than the dividend itself is SUPERVALU's ability to keep that cash rolling. mark for My Articles similar articles
The Motley Fool
August 13, 2010
Jim Mueller
How Well Do You Use Cash, Rite Aid? Between retail and pharmacy, Rite Aid isn't doing too well, at least when compared to purer plays on either sector. mark for My Articles similar articles
The Motley Fool
June 24, 2005
Stephen D. Simpson
Is Rite Aid a Real Value Stock? Reality hasn't caught up with the company's turnaround prospects. Rite Aid must deal with a lot of debt and preferred equity if and when it recovers. mark for My Articles similar articles
The Motley Fool
April 13, 2007
Ryan Fuhrmann
Rite Aid's Right-Size Ambitions If the retail pharmacy chain can improve its net margins, reduce debt, and smoothly integrate its latest acquisition, the stock's upside would be substantial. mark for My Articles similar articles
The Motley Fool
August 3, 2006
Ryan Fuhrmann
YRC Keeps on Truckin' The trucking firm is in business for the long haul. Investors, here is a market leader trading for less than 10 times earnings. mark for My Articles similar articles
The Motley Fool
July 14, 2009
Selena Maranjian
Companies With Killer Price-to-Sales Ratios They're not always as enticing as they appear. mark for My Articles similar articles
The Motley Fool
May 9, 2011
Sean Williams
This Stock Could Fall By 93% Diluted share offerings and continued losses may crush shareholder value at trucker YRC Worldwide. mark for My Articles similar articles
The Motley Fool
January 5, 2007
Matthew Crews
Rite Aid's Baby Steps If Rite Aid does manage 5% operating margins, this pharmacy chain's shares will get the love they deserve. mark for My Articles similar articles
The Motley Fool
June 29, 2007
Ryan Fuhrmann
Rite Aid's Recent Remedy Will increased market clout lead the drugstore operator to new highs? Investors, take note. mark for My Articles similar articles
The Motley Fool
July 30, 2010
Jeremy Phillips
Technically, YRC Worldwide Is a Buy Looking at the indicators, you should buy YRC Worldwide. mark for My Articles similar articles
The Motley Fool
June 11, 2007
Mike Cianciolo
Rite Aid's Generic Sales The drugstore chain gradually increases sales, and catches up to the big boys in one way. Investors, take note. mark for My Articles similar articles
The Motley Fool
March 8, 2005
Seth Jayson
Rite Aid Wretched? Value investors may be interested in Rite Aid. mark for My Articles similar articles
The Motley Fool
September 29, 2011
Navjot Kaur
Should You Write Off Rite Aid? Rite Aid posts a relatively better quarter as wellness rewards the company. mark for My Articles similar articles
The Motley Fool
October 12, 2010
Matt Koppenheffer
YRC Worldwide Shares Plunged: What You Need to Know Shares of trucker YRC Worldwide were down more than 10% in intraday trading -- yes, again -- after a very pessimistic report from a Morgan Keegan analyst. mark for My Articles similar articles
The Motley Fool
September 22, 2005
Stephen D. Simpson
Rite Aid Not Right Yet The bleeding seems to have stopped at this pharmacy, but recovery could be a long and slow road. Intrepid, not to mention patient, investors may see potential here, but there are far better turnaround ideas to be had. mark for My Articles similar articles
The Motley Fool
June 25, 2007
Ryan Fuhrmann
Foolish Forecast: Rite Aid Aims for Healthy Growth The drugstore operator is set to report its first-quarter earnings. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
September 22, 2006
Ryan Fuhrmann
More in Store at Rite Aid? The retail pharmacy posted strong second-quarter sales, and an acquisition could help long-term results. Investors, take note. mark for My Articles similar articles
The Motley Fool
September 22, 2010
Rich Smith
Foolish Forecast: A Prescription for Rite Aid Investors Here's what you need to know before earnings come out tomorrow. mark for My Articles similar articles
The Motley Fool
December 8, 2009
Eric Bleeker
Are These the Most Expensive Tech Companies? Take a look at IT companies that may be overvalued. mark for My Articles similar articles
The Motley Fool
January 3, 2012
Sean Williams
2012 Preview: Level 3 Communications Here's what the new year has in store for Level 3 Communications. mark for My Articles similar articles
The Motley Fool
September 27, 2010
Rick Aristotle Munarriz
YRC Keeps On Truckin' Teamsters and trucker make inroads. mark for My Articles similar articles
The Motley Fool
July 6, 2004
Alyce Lomax
Not Ready for Rite Aid Can the drugstore chain hold a candle to the competition? Its shares are trading at 22 times forward earnings, making it a seemingly less-than-advantageous time to place a bet on them. mark for My Articles similar articles
The Motley Fool
November 3, 2010
Don't Be Afraid of Heights: The One Thing You Need to Know About High P/E Ratios Companies with high P/E ratios are simply being rewarded for what the market sees as future profit potential. mark for My Articles similar articles
The Motley Fool
January 21, 2011
Jim Royal
Trucking's Magic Formula This mechanical strategy could be magic. mark for My Articles similar articles
The Motley Fool
July 22, 2011
Anand Chokkavelu
9 Small Biotechs Near 52-Week Lows Here are nine companies in this space that are within 20% of their 52-week lows and have market caps between roughly $200 million and $500 million. mark for My Articles similar articles
The Motley Fool
September 26, 2007
Ryan Fuhrmann
Foolish Forecast: Does Rite Aid Have the Right Rx? The retail pharmacy is set to release it second-quarter financial results. Investors, here is what you can expect to see. mark for My Articles similar articles
The Motley Fool
July 19, 2011
Anand Chokkavelu
7 Biotechs Near 52-Week Lows Here are the largest seven companies in biotech stocks that are within 20% of their 52-week lows. mark for My Articles similar articles
The Motley Fool
December 11, 2006
Matthew Crews
Rite Aid: Comps Mean Competition The pharmacy chain reported positive same-store results for November. Investors, take note. mark for My Articles similar articles
The Motley Fool
September 30, 2010
Rick Aristotle Munarriz
YRC Puts It In Reverse The trucking specialist is executive a 1-for-25 reverse split. mark for My Articles similar articles
The Motley Fool
June 29, 2011
Avoid This Trucking Stock Our investing community's latest pick to avoid is YRC Worldwide, which is wrestling to stay out of bankruptcy. mark for My Articles similar articles
The Motley Fool
July 20, 2010
Seth Jayson
Show Me the Money, YRC Worldwide Shipper YRC Worldwide turned -6% of its revenue into free cash flow, or rather, it burned all that revenue, then burned some more cash. That's none too impressive. But it always pays to compare that figure to sector and industry peers and competitors, to see how the company stacks up. mark for My Articles similar articles